M E A

Transcription

M E A

Curriculum vitae: Michael E. Albo, MD
MICHAEL E. ALBO, MD, FACS
Clinical Professor of Surgery/Urology
Vice Chair of Urology, UC San Diego Health System
UNIVERSITY OF CALIFORNIA, SAN DIEGO
Clinic Address:
UC San Diego Women’s Pelvic Medicine Center
9350 Campus Point Drive, Ste 2A, MC 0974
La Jolla, CA 92037-0974
Academic Address:
Department of Urology
UC San Diego Health System
200 West Arbor Drive #8897
San Diego, CA 92103-8897
EDUCATION:
Undergraduate:
B.A.
1979 – 1983
University of Notre Dame
South Bend, Indiana
1981 – 1982
University of Innsbruck
Innsbruck, AUSTRIA
Medical School:
M.D.
1984 – 1988
University of Utah
Salt Lake City, Utah
Internship:
Intern & Assistant Resident
General Surgery
1988 – 1990
University of Virginia Health
Sciences Center
Charlottesville, VA
Residency:
Assistant Resident
Urology
1991 – 1993
Sciences Center
Charlottesville, VA
Chief Resident
Urology
1993 – 1994
Sciences Center
Charlottesville, VA
Fellow
Female Urology & Urodynamics
1995 – 1996
University of California, Los Angeles
Health Sciences Center
Los Angeles, CA
Fellowship:
ADDITIONAL TRAINING:
2012 – 2013
UCSD Health Sciences Leadership Academy: an 18-month in-depth
course for select physician leaders
MEDICAL LICENSURE:
California
G81920
1995- present
1|P a g e
BOARD CERTIFICATION:
Diplomat, American Board of Urology
Female Pelvic Medicine/Reconstructive Surgery
1998 -present
2007 (recertified)
2013
PROFESSIONAL POSITIONS:
1996 – 2002
Assistant Clinical Professor of Surgery/Urology
Division of Urology
San Diego, CA
1996 – present
Urology Director
Spinal Cord Injury Unit
Veterans Affair Medical Center
La Jolla, CA
1997 – 2008
Urology Section Chief
Veterans Affairs Medical Center
La Jolla, CA
2000 – present
Co-Director
Women’s Pelvic Medicine Center
San Diego, CA
2002 – 2008
Associate Clinical Professor of Surgery/Urology
Division of Urology
San Diego, CA
2008 – present
Clinical Professor of Surgery/Urology
Division of Urology
San Diego, CA
2008 – present
Research Scientist
Veterans Medical Research Foundation
La Jolla, CA
2011 – present
Vice Chief
Division of Urology
UC San Diego School of Medicine
La Jolla, CA
2013 – present
Vice Chair
Department of Urology
San Diego, CA
2|P a g e
HONORS AND AWARDS:
1988
1988
1988
1991
1998
2004 – 2011; 2013
2006
2006
2007
2007
2009
2009
2011 - 2012
2012
2012
Honors in Medicine, University of Utah Medical School
Honors in Obstetrics and Gynecology, University of Utah Medical
School
Alpha Omega Alpha, University of Utah Medical School
Teaching Assistant Award in Anatomy, University of Virginia
Pfizer Scholar in Urology Award for Research
San Diego’s Top Doctors, San Diego Magazine, in partnership with San
Diego Medical Society
3rd Place - Best of Poster Session I, 82nd Annual Meeting of the
Western Section AUA, Maui, HI
3rd Place Overall Poster Winner, 82nd Annual Meeting of the Western
Section AUA, Maui, HI
3rd Place Poster, Western Section, American Urologic Association
Annual Meeting
Top Ten Reviewer for the journal Neurourology and Urodynamics
Zimskind Award, Society for Urodynamics and Female Urology
Employee Excellence Award, San Diego VA Medical Center
U.S. News & World Report’s “Top Doctors” – noted among the top
10% of urologists in the nation
Best Poster in Poster Session 15: “Incontinence Surgery: How to
choose the right technique?” 27th Annual European Association of
Urology (EAU) Congress, Paris, France
UC San Diego CARES Pin (Clinical Advancement & Recognition of
Excellence in Service) – patient donation made to UCSD Health Sciences
in association with National Doctors’ Day and in honor of Dr. Albo.
CERTIFICATE AND LICENSES:
State of California, Medical Board of California
DEA Certificate
Board Certification, Diplomat, American Board of Urology
Holmium Laser Course
Transurethral Needle Ablation Course
Laparoscopy Course
Urolithiasis Course (AUA)
Peer Review Course (AUA)
Collagen Implantation Certification
Fluoroscopy License
Renal Shock Wave Lithotripsy using Siemens Lithostar
Indigo Laser
Protection of Human Research Subjects, certificate
UCSD Health Sciences Leadership Academy, Physician Certificate of Completion,
Female Pelvic Medicine & Reconstructive Surgery (FPMRS) Certification – (Pending)
PROFESSIONAL MEMBERSHIPS:
1998 – present
Alpha Omega Alpha Honor Society
3|P a g e
1992
1994
1996
1996
–
–
–
–
present
present
present
present
1997 – present
1997
1997
1998
1998
1998
2000
2001
2002
2004
2004
2005
–
–
–
–
–
–
–
–
–
–
–
present
present
present
present
present
present
present
present
present
present
present
American Urological Association
American Medical Association, Member
American Urological Association, Member
San Diego Urological Society, Member
• Secretary: 1997-99;
• Vice President: 1999-00;
• President: 2001-02
Western Section, American Urological Association, Member
Regional Representative
California Medical Association, Member
San Diego County Medical Society, Member
California Urologic Society, Member
International Continence Society, Member
Society of Urodynamics and Female Urology, Member
American Urogynecologic Society, Member
American College of Surgeons, Fellow
Société Internationale d’Urologie (United States Section), Member
Society of University Urologists
American Association of University Professors
San Diego Chapter of the American College of Surgeons
SERVICE TO THE NATIONAL INSTITUTES OF HEALTH (NIH):
1998
NIDDK: Clinical issues in urinary incontinence. NIDDK Research
Workshop: Issues and Opportunities in Urinary Incontinence, Bethesda,
MD. January 23-24, 1998
1999-2010
NIH: Member, External Advisory Committee for Skin-CNS-Bladder Reflex
Arc for Micturition after SCI
1999-2003
NIH: Member, External Advisory Committee for the Interstitial Cystitis
Clinical Trials Group
2001-present
URINARY INCONTINENCE TREATMENT NETWORK (UITN) – PI
• Steering Committee – Member (2001-present)
• Publication & Presentations Committee – Member (2001-present)
• Stress Incontinence Safety and Treatment Efficacy Trial (SISTER)
Urodyamics Working Group – Member (2001-present)
• Behavioral Efficacy Drug Intervention Trial (BE-DRI) Protocol
Development Committee – Member (2002-present)
• SISTEr Complications Working Group – Member (2003-present)
• Ancillary Studies Committee – Member (2006-present)
• Trial of Midurethral Slings (TOMUS): Complications Committee –
Member (2006-present)
• Trial of Midurethral Slings (TOMUS): Eligibility Committee – Member
(2006-present)
• Mixed Incontinence: Medical or Surgical Approach Trial (MIMOSA)
Protocol Development Committee – Member (2007-2008)
2003-2007
NIH: Member, Data Monitoring Safety Board (DSMB), Urologic Pelvic
Pain Clinical Research Network
4|P a g e
2007
NIH-NIDDK: Reviewer, Contract proposal submitted for RFP NIH-NIDDK06-07, "UROLOGIC DISEASES IN AMERICA”
2007
NIDDK: Reviewer, UPPCRN Cycle III Ancillary Studies Applications
2009
NIH: Reviewer, American Recovery and Reinvestment Act (ARRA)
Challenge Grant
2010-present
NIH/NIDDK: Chairman, External Advisory Committee Meeting of the
External Advisory Committee (EAC) for the Study of Nerve Rerouting
Treatment for Neurogenic Bladder in Spina Bifida
2011
NIDDK / NIH: Member, Planning Committee for Meeting on
Measurements of Urinary Symptoms (MOMUS), Bethesda, MD
2011
NIDDK/NIH: Speaker, “What Domains are Missing in AUA SS for
Clinical Care?” National Institute of Diabetes and Digestive and Kidney
Diseases (NIDDK) Meeting on Measurements of Urinary Symptoms
(MOMUS), Bethesda, MD, November 14 – 15, 2011
2011
NIDDK/NIH: Break-Out Session Leader, “What is Missing in Current
Measurement Tools for Female LUTD?” National Institute of Diabetes
and Digestive and Kidney Diseases (NIDDK) Meeting on Measurements of
Urinary Symptoms (MOMUS), Bethesda, MD, November 14 – 15, 2011
2011
NIDDK/NIH: Session Moderator, “Phenotypes, Clinical Conditions, and
Impact on Measurement”, National Institute of Diabetes and Digestive
and Kidney Diseases (NIDDK) Meeting on Measurements of Urinary
Symptoms (MOMUS), Bethesda, MD, November 14 – 15, 2011
2012
NIH: Reviewer, Clinical Center and Data Coordinating Center U01 for
RFA titled “Symptoms of Lower Urinary Tract Dysfunction Research
Network (LURN) (U01).” July 2012
SERVICE TO PROFESSIONAL SOCIETIES:
2004-present
American Urological Association (AUA) Research Council
• Member
• Co-Chair: Communications Work Group 2009-2011
2010
American Urological Association (AUA): Reviewer, AUA Research
Scholars Program (15 Research Training Grants Awarded) Oct 2010
2010
American Urological Association (AUA): Co-Author, Section 16:
Urodynamics Section of the AUA Urology Core Curriculum – an
interactive online formatted document
2011
American Urological Association (AUA): Peer Reviewer, AUA’s
Evidence Based Reviews in Urology (EBRU), Reviewed JAMA article
entitled “Behavioral Therapy With or Without Biofeedback and Pelvic
Floor Electrical Stimulation for Persistent Postprostatectomy
Incontinence: A Randomized Controlled Trial.”
5|P a g e
2011
American Urological Association (AUA): Peer Reviewer, AUA
Urodynamics Guidelines, Nov 2011
2011
American Urological Association (AUA): Peer Reviewer, AUA Overactive
Bladder Guidelines, Dec 2011
2012
American Urological Association (AUA): Reviewer, Special Emphasis
Panel/Scientific Review Group 2013/01 ZDK1 GRB-N (J3), Oct 2012
2012
Society Urodynamics, Female Pelvic Medicine & Urogenital
Reconstruction (SUFU): Reviewer, Abstracts to SUFU Annual Meeting,
Oct 2012
2013
Society Urodynamics, Female Pelvic Medicine & Urogenital
Reconstruction (SUFU): Program Chair, “Utility of Urodynamics in
Clinical Practice”, SUFU Annual Meeting, San Diego, CA, May 4, 2013
2013
American Urological Association (AUA): Moderator, POD32:
Urodynamics/Incontinence/Female Urology: Female Urology (II), 2013
Annual AUA Meeting, San Diego, CA, May 7, 2013
PRESENTATIONS – INTERNATIONAL & NATIONAL MEETINGS:
1996
Albo M. “Anterior flap, Extraperitoneal Cystoplasty.” 72nd Western Section
AUA Annual Meeting, San Diego, CA. July 28 - August 1, 1996
1996
Albo M. “Repair of Grade IV Cystocele.” 72nd Western Section AUA Annual
Meeting, San Diego, CA. July 28 - August 1, 1996
1996
Albo M. Speaker, “Prostate Surgery - 1996.” Texas Club of Internists Annual
Meeting, San Diego, CA. September 30 - October 4, 1996
1996
Albo M. Speaker, Evaluation and Medical Treatment of Benign Prostatic
Hyperplasia. Texas Club of Internists Annual Meeting, San Diego, CA.
September 30 - October 4, 1996
1997
Albo M. Speaker, “Urodynamic Evaluation of Spinal Cord Injury Patients.”
Paralyzed Veterans of America, San Diego, CA. May 2, 1997
1997
Albo M. “Four-year follow-up of urolume urethral wall stent use in the
treatment of detrusor sphincter dyssynergia.” 73rd Western Section AUA Annual
Meeting, Salt Lake City, UT. September 14-18, 1997
1997
Albo M. “Bladder cancer surveillance in spinal cord injury patients with chronic
indwelling catheters.” 73rd Western Section AUA Annual Meeting, Salt Lake
City, UT. September 14-18, 1997
1998
Albo M. Faculty, “Pitfalls of Urodynamics. 4th National Multi-Specialty Nursing
Conference on Urinary Continence, Orlando, FL. January 15-18, 1998
1998
Albo M. Speaker, Management of Intrinsic Sphincteric Deficiency. Wound
Ostomy Continence Nurses Society, Salt Lake City, UT. June 17, 1998
1998
Albo M. Speaker, “Incontinence/Overactive Bladder.” Phoenix Urological
Society, Phoenix, AZ. July 8, 1998
6|P a g e
1998
Albo M. Speaker, “Overactive bladder.” San Diego Urological Society, San
Diego, CA. July 16, 1998
1998
Albo M. Faculty, “Understanding Urodynamics Seminar”, Society of Urologic
Nurses & Associates 4th Annual Fall Institute, Las Vegas, NV. October 23, 1998
1998
Albo M. “A Comparison of Ultrasound and Computerized Tomography in the
Upper Urinary Tract Screening of Spinal Cord Injury Patients.” 74th Western
Section AUA Annual Meeting, Big Island, HI. October 25-30, 1998
1998
Hagey S, Albo M, Monga M, Parsons CL, Favazza T, Liyanage M, Mills L. “The
Potassium Chloride Test in Men with Lower Urinary Tract Symptoms (LUTS) and
it’s Correlation with Urodynamic Parameters.” 74th Western Section AUA
Annual Meeting, Big Island, HI. October 25-30, 1998
1998
Albo M. Speaker, “Surgical Management of SUI.” Society of Urologic Nurses &
Associates (SUNA) Southern California Chapter, 74th AUA Western Section
Annual Meeting, Big Island, HI. October 25, 1998
1999
Albo M. Speaker, “Pharmacotherapy of Urinary Incontinence.” 1st Annual
Meeting, Wound Ostomy Continence Nurses Society, Austin, TX. February 5,
1999
1999
Albo M. “Necrotizing Fasciitis of the Penis with Corporal Emphysema.” 75th
Annual Western Section AUA Meeting, Monterey, CA. September 26-30, 1999
1999
Albo M. “Unusual Bilateral Renal Masses.” 75th Annual Western Section AUA
Meeting, Monterey, CA. September 26-30, 1999
2000
Albo M. Speaker, “Pathophysiology of Urinary Incontinence.” Society of Urologic
Nurses & Associates, Sheraton Hotel, San Diego, CA. September 22-24, 2000
2002
Albo M. Faculty, Modern Management of Urinary Incontinence.” Orlando, FL.
AUA Annual Meeting, May 28, 2002
2004
Albo M. “Bosentan, an Endothelin Receptor Antagonist, Potentiates Nitric Oxidemediated Erectile Response in an Aging Brown-Norway Rat Model.” AUA Annual
Meeting, San Francisco, CA. May 8-13, 2004
2005
Albo M. Faculty, “Urodynamics in the Management of the Incontinent Patient.”
Female Urology Session, Educational Retreat of the Western Section AUA,
Vancouver, B.C., August 6, 2005
2006
Albo M. Moderator, Incontinence/Pelvic Floor Scientific Program. 82nd Western
Section AUA Annual Meeting, Maui, HI, October 24, 2006
2006
Albo M. Faculty, “Stress Urinary Incontinence”. Review and Examination
Preparation Course (PREP-C#1) 82nd Western Section AUA Annual Meeting,
Maui, HI, October 23, 2006
2007
Albo M. Speaker, Plenary Session - State of the Art Lecture. “The Urinary
Incontinence Treatment Network & Primary Outcomes of the SISTEr Trial”.
AUA Annual Meeting, AUA, Anaheim, CA, May 2007
2007
Albo, M. Speaker, “Evaluation of Voiding Dysfunction and Management.” Prep
Course: Urodynamics and Voiding Dysfunction, 83rd Western Section AUA
Annual Meeting, Scottsdale, AZ, October 29, 2007
7|P a g e
2007
Albo M. Speaker, “The Female Patient: Evaluation and Management.” 83rd
Western Section AUA Annual Meeting, Scottsdale, AZ, October 29, 2007
2008
Albo M. Speaker, “State of the Art: Spinal Cord Injuries.” James C. Kimbrough
Urological Seminar, San Diego, CA. January 23, 2008
2008
Albo M. Speaker, Interrater Reliability of Pressure Flow Study Interpretation in
the SISTEr Trial.” AUA Annual Meeting, Orlando, FL. May 2008
2008
Albo M. Expert Panelist, “Optimal Bladder Management for SCI Patients: Oral
and Intravesical Treatments.” ASIA Annual Meeting 2008, San Diego, CA. June
2008
2009
Albo M. Speaker, “UITN SISTEr STUDY: What did we learn from all the
Urodynamics Data?” Society of Urodynamics, Female Pelvic Medicine and
Urogenital Reconstruction 7th Annual Winter Meeting, Las Vegas, NV. February
25-28, 2009
2009
Albo M. Treatment of Male and Female Incontinence. Utah Urologic Society
Annual Meeting, March 2009
2009
Albo M. Visiting Professor, “Pelvic Floor Prolapse.” University of Utah
Department of Urology Grand Rounds, Pelvic Prolapse, Salt Lake City, UT.
March 2009
2009
Albo M. Speaker, Plenary Session. “Randomized Clinical Trials for the
Treatment of SUI: A Critical Evaluation” AUA Annual Meeting, Chicago, IL. May
2009
2009
Albo M. Expert Panelist, “Pelvic Floor Reconstruction: A Case-Based
Discussion.” 85th Western Section AUA Annual Meeting 2009, Las Vegas, NV.
October 2009
2010
Albo M. Speaker, “Neuromodulation with Neurotoxins: Clinical Trial Updates
for OAB Conditions.” Society of Urodynamics, Female Pelvic Medicine and
Urogenital Reconstruction 8th Annual Winter Meeting, St Petersburg, FL.
February 23- 27, 2010
2010
Albo M. Speaker, Plenary Session. “The Results of the Randomized Trial of
Retropubic and Transobturator Midurethral Slings (TOMUS).” AUA Annual
Meeting, San Francisco, CA. May 2010
2010
Albo M. Speaker, “Urinary Incontinence: Integrating Basic and Clinical Research
Perspectives.” AUA Research Foundation/Society for Basic Urological Research,
Summer Research Conference, August 2010
2011
Albo M. Speaker, “Point Counterpoint – Interstim vs. Botulinum Toxin.” 87th
Western Section AUA Meeting, Vancouver, CA, August 2011
2011
Albo M. Visiting Professor, “Clinical Trial Results from the Urinary Incontinence
Treatment Network”, Department of Urology Grand Rounds, University of
California, San Francisco, December 2011
2012
Albo M. Faculty, “Pelvic Prolapse and Stress Urinary Incontinence”, Exam
Preparation Course (Prep-C), 88th Western Section AUA Meeting, Big Island,
Hawaii, October 7-12, 2012
8|P a g e
2013
Albo M. Moderator, Female Urology Podium Session.10th Annual Winter Meeting
of the Society of Urodynamics, Female Pelvic Medicine and Urogenital
Reconstruction (SUFU), Caesars Palace, Las Vegas, NV, February 28, 2013
2013
Albo M. Speaker, “SUFU Update for Pelvic Floor Disorders Network.” 10th
Annual Winter Meeting of the Society of Urodynamics, Female Pelvic Medicine
and Urogenital Reconstruction (SUFU), Caesars Palace, Las Vegas, NV, March 2,
2013
2013
Albo M. Speaker, State-of-the-Art Lecture. “Urinary Incontinence in Older
Adults – Data from the Urinary Incontinence Treatment Network (UITN).”
American Society for Geriatric Urology Annual Meeting, San Diego, CA, May 5,
2013
2013
Albo M. Speaker, Plenary Session “Point Counterpoint: Occult SUI, What do the
Trials Teach Us?” AUA Annual Meeting, San Diego, CA, May 6, 2013
CONTINUING MEDICAL EDUCATION (CME) & POSTGRADUATE COURSES:
2000
Albo M. Faculty, “Hematuria” Advances in Urology & Gynecology. Post-graduate
Course, San Diego, CA. February 10-12, 2000
2000
Albo M. Faculty, “Neurogenic Bladder and Interstitial Cystitis.” Department of
Medicine Grand Rounds, Scripps Mercy Hospital, San Diego, CA. February 8,
2000
2001
Albo M. Faculty, Urinary Incontinence and Pelvic Floor Dysfunction.” Advances
in Urology & Gynecology for Primary Care, Post-graduate course. San Diego, CA.
May 10-11, 2001
2002
Albo M. Faculty, “The ABC’s of Voiding.” Current Trends in Men’s and Women’s
Health, UCSD Continuing Education. Del Mar Hilton, San Diego, CA. November
9, 2002
2002
Albo M. Bladder overactivity: New concepts in the etiology. 11th Annual
Urogynecology and Disorders of the Female Pelvic Floor. Scottsdale, AZ. April
18-20, 2002
2002
Albo M. Pharmacologic management of bladder overactivity. 11th Annual
Urogynecology and Disorders of the Female Pelvic Floor. Scottsdale, AZ. April
18-20, 2002
2002
Albo M. Urologic implications of spinal cord injury. Guest lecturer: Wednesday
morning core lecture series. Naval Medical Center, Urology Department. July
10, 2002
2008
Albo, M. Faculty, “Female Urinary Incontinence” UCSD Topics and Advances in
Internal Medicine Conference, San Diego, CA. March 7, 2008
2008
Albo M. Faculty, “Cystitis” UCSD Topics and Advances in Internal Medicine
Conference, San Diego, CA. March 7, 2008
9|P a g e
2008
Albo M. Invited Faculty, “Outcomes of Stress Urinary Incontinence Surgery –
How Should We Measure Success? “ UCLA State-of-the-Art Urology Conference,
Marina del Rey, CA. March 14, 2008
2008
Albo M. Invited Faculty, “Which Sling I Prefer and Why.” UCLA State-of-the-Art
Urology Conference, Marina del Rey, CA. March 14, 2008
2008
Albo M. Faculty, “Botulim Toxin and Other Neuromodulators for the Treatment
of Refractory Voiding Dysfunction.” CME Workshop. Haymarket Medical.
Chicago IL. June 7, 2008
2009
Albo M. Faculty, “Female Pelvic Floor Anatomy and Physiology.” 2nd Annual
UCSD Urology Postgraduate Course, La Jolla, CA. February 20-21, 2009
2009
Albo M. Faculty, “State of the Evidence and Clinical Trial Networks.” 2nd
Annual UCSD Urology Postgraduate Course, La Jolla, CA. February 20-21,
2009
2009
Albo M. Faculty, “How Do We Measure Treatment Success?” 2nd Annual UCSD
Urology Postgraduate Course, La Jolla, CA. February 20-21, 2009
2009
Albo M. Faculty, “Artificial Urinary Sphincters.” 2nd Annual UCSD Urology
Postgraduate Course, La Jolla, CA. February 20-21, 2009
2009
Albo M. Speaker, “Urinary Incontinence.” UCSD Stein Institute for Research in
Aging Public Lecture Series. November 2009
2010
Albo M. Invited Faculty, “Clinical Trials in Female Stress Urinary Incontinence –
What have we learned?” 23rd Annual Aspen Urological Conference, Aspen, CO.
February 8-11, 2010
2010
Albo M. Invited Faculty, “Management of Post-Prostatectomy Incontinence:
Male Sling vs. Artificial Urinary Sphincter.” 23rd Annual Aspen Urological
Conference, Aspen, CO. February 8-11, 2010
2010
Albo M. Invited Faculty, “Neuromodulation for the Treatment of OAB.” 23rd
Annual Aspen Urological Conference, Aspen, CO. February 8-11, 2010
2010
Albo M. Invited Faculty, “Indications and Complications of Mesh in Prolapse and
Incontinence Repairs.” 23rd Annual Aspen Urological Conference, Aspen, CO.
February 8-11, 2010
2011
Albo M. Invited Faculty, “Advances in the Diagnosis and Treatment of Urinary
Incontinence,” USC/Loma Linda University’s 20th Annual Contemporary Issues
in Urology Seminar. Mammoth, CA, February 26 – March 1, 2011
2012
Albo M. Moderator, “Master Robotics for Urologic Oncology and Pelvic Prolapse:
New Technology and Outcome” 5th Annual UCSD Postgraduate Course
2012
Albo M. Speaker, “Updates in Urogynecology”. CME Seminar Series, UC San
Diego Women’s Pelvic Medicine Center. San Diego, CA, August 11, 2012
2012
Albo M. Speaker, “Diagnosing, Managing and Treating Urologic Injuries after
Gynecologic Surgery.” 56th Annual T. Hart Baker, MD Obstetrics and
Gynecology Symposium, Kaiser Permanente, San Diego, CA, September 9, 2012
10 | P a g e
2012
Albo M. Speaker, “Neuromodulation in the Treatment of Overactive Bladder”
Updates in Female Pelvic Medicine CME Seminar Series, UC San Diego Women’s
Pelvic Medicine Center, October 27, 2012
2013
Albo M. Faculty and Session Chair, “Female Urology” 6th Annual UCSD
Postgraduate Course, “Clinical Guidelines and Beyond: Update on Current
Recommendations and Discussion of Controversies” March 22, 2013
SERVICE TO THE VETERAN’S HEALTH SCIENCES:
1997-2009
1997-present
1998-present
1998
1998 – 2000
Chief, Urology Section
Director, Urology Section of Spinal Cord Injury Unit
VA Surgical Staff Committee
Chair, Care of Patient Committee, VA Joint Commission on Hospital
Accreditation
VA Cancer Committee
SERVICE TO THE UNIVERSITY OF CALIFORNIA:
1999 – 2002
1999-present
1999-present
2003-present
2004-2007
2004-present
2005
2005-present
2008-present
2009-2013
2009
2009-present
2009-present
2011-present
2012-present
2013
2013
COMMITTEES
UCSD Health Sciences - Electives Committee
UC San Diego Health Systems - Women’s Pelvic Medicine Center, CoDirector and Founder
UCSD Health Sciences - Physician Assessment and Clinical Education
Program (PACE), Division of Urology Representative
UCSD Health Sciences - Stein Institute for Research on Aging, Affiliated
Faculty
UC San Diego Health Systems - Electronic Medical Records Committee
UC San Diego Health Systems - Medical Risk Management Committee
UC San Diego Health Systems - VA Interface Commission
UCSD Health Sciences - Clinical Investigation Institute
UC Health Sciences - Academy of Clinician Scholars (AOCS)
• Member – 2008-presentt
• Chair, Membership Committee – 2011- present
UC San Diego Health Systems - Department of Surgery Quality
Improvement Committee (QIDR), Urology representative
UCSD Health Sciences - Division of Urology 2nd Annual Postgraduate
Course, Co-director
UC San Diego Health Systems - Department of Surgery, EPIC Committee,
Urology representative
UC San Diego Health Systems - University Ambulatory Surgery Center
(UASC), Medical Executive Committee
UC San Diego Health Systems - Surgical Care Improvement Project
(SCIP) Committee
UCSD Health Sciences - Nominating Committee
UC San Diego Health Systems - Jacobs Medical Center (JMC), Pre-Post
Op & PACU User Group Committee
UCSD Health Sciences - Department of Surgery, Mentoring &
Advancement Action Team Committee Member
11 | P a g e
2013-present
2013-present
2013-present
2013-present
Nov 1996
UC San Diego Health Systems - Outpatient Pavilion Work Group,
Planning Committee Member
UCSD Health Sciences - Department of Surgery Business Office Advisory
Group
UCSD Health Sciences - Division of Urology Residency Program, ACGME
Clinical Competency Committee member
UC San Diego Health Systems - Quality Improvement Committee, Dept of
Urology Representative
LECTURES
Albo M. Surgical treatment of stress urinary incontinence. UCSD
Department of Surgery Grand Rounds, UCSD Medical Center, San Diego,
CA. November 23, 1996
Feb 1997
Albo M. Evaluation and treatment of urinary incontinence. UCSD
Department of Family Practice Grand Rounds, February 26, 1997
Oct 1998
Albo M. Bladder cancer: Muscle-invasive disease. VAMC
Hematology/Oncology Department, La Jolla, CA. October 14, 1998
Dec 1998
Albo M. Urinary incontinence and voiding dysfunction. “Best and
Brightest Clinical Lecture”, UCSD Thornton Hospital, La Jolla, CA.
December 8, 1998
Sep 1999
Albo M. Women’s Incontinence Update: What’s New in Treatment.
UCSD School of Medicine, September 16, 1999
Fall 2007
Albo M. Urinary Tract; Human Anatomy Course Lecture, UCSD Medical
School
Nov 2007
Albo M. Interstim for the Treatment of Overactive Bladder. Professor’s
Lecture, UCSD Division of Urology
Spr 2008
Albo M. Neurology of Bladder, Bowel, and Sexual Function and
Dysfunction. Basic Neurology Course Lecture, UCSD Medical School
Fall 2008
Albo M. Urinary Tract: Human Anatomy Course Lecture, UCSD Medical
School
Jan 2009
Albo M. Neurourology. Professor’s Lecture, Division of Urology, UCSD.
Spr 2009
Dysfunction. Basic Neurology Course Lecture, UCSD Medical School
May 2009
Albo M. Complications of Stress Urinary Incontinence Surgery.
Professor’s Lecture, Division of Urology, UCSD
Jul 2009
Albo M. Urinary Incontinence: Evaluation and Treatment. Nurse
Practitioners Noon Lecture at the Veteran’s Administration Hospital, San
Diego
Fall 2009
Albo M. Basic Urology. Human Anatomy Course Lecture, UCSD Medical
School
12 | P a g e
Jan 2010
Albo M. Lower Urinary Tract Fistulas and Urethral Diverticulum.
Department of Reproductive Medicine Urogynecology Seminars, January
2010
Mar 2010
Albo M. Mesh in Pelvic Prolapse Repair. Professor’s Lecture, Division of
Urology, UCSD
Spr 2010
Dysfunction. Basic Neurology Course Lecture, UCSD Medical School,
Spring Quarter 2010
May 2010
Albo M. Urodynamics in the Evaluation of Lower Urinary Tract
Symptoms (LUTS). Professor’s Lecture, Division of Urology, UCSD
Sep 2010
Albo M. Female Pelvic Anatomy. Professor’s Lecture, Division of Urology,
UCSD
Oct 2010
Albo M. Vesicovaginal Fistula. Professor’s Lecture, Division of Urology,
UCSD
Nov 2010
Albo M. Vesicovaginal Fistula. Professor’s Lecture, Division of Urology,
UCSD
Jan 2011
Albo M. Urinary Tract; Human Anatomy Course Lecture, UCSD Medical
School
Mar 2011
Albo M. Faculty, 4th Annual UCSD Postgraduate Course, Moderator –
Question & Answer; Case Discussion, La Jolla, CA, March 19, 2011
May 2011
Albo M. Lecturer. Introduction to Clinical Medicine Course, UCSD
Medical School
Aug 2011
Albo M. “Anterior Urethral Trauma and Stricture Reconstruction,
Professor’s Lecture, Division of Urology, UCSD
Aug 2011
Albo M. “Posterior Urethral Strictures,” Professor’s Lecture, Division of
Urology, UCSD
Dec 2011
Albo M. “Incontinence”, University of California, San Francisco,
Department of Urology Grand Rounds, Parnassus Campus, San
Francisco, CA, December 14, 2011
Jan 2012
Albo M. “Female Incontinence (Physical Exam Urodynamics)” Professor’s
Lecture, Division of Urology, UCSD
Jan 2012
Albo M. “Surgery for Incontinence” Professor’s Lecture, Division of
Urology, UCSD
May 2012
Albo M. “Lower Urinary Tract Fistulas and Urethral Divertiulum”,
Urogynecology Seminar, Department of Reproductive Medicine, UCSD
Aug 2012
Albo M. Other Neurological Conditions and Their Impact on Voiding,
Professor’s Lecture, UCSD Division of Urology
13 | P a g e
Jan 2013
Albo M. Pelvic Prolapse Repair. Professor’s Lecture, Division of Urology,
UCSD
Feb 2013
Albo M. Female Pelvic Anatomy. Professor’s Lecture, Division of
Urology, UCSD
Sep 2011
Sep 2011
Oct 2011
Sep 2012
Dec 2012
Mar 2013
Jan 2000
UCSD LAB PROCTORING
Proctor, Surgical Robotics Lab, Division of Urology, UCSD
Proctor, Cadaver Dissection Lab with Dr. Justin Brown, UCSD
Proctor, Resident Surgical Lab, Division of Urology, UCSD
Proctor, Resident Male Incontinence Lab, Division of Urology, UCSD
COMMUNITY SERVICE LECTURES
Albo M and Nager C. Incontinence and prolapse in this millennium.
UCSD Women’s Continence Center, Thornton Hospital, La Jolla, CA.
January 29, 2000
Oct 2008
Albo M. Women’s Health Matters: Pelvic Floor Function, Dysfunction
and Treatment. Faculty Ambassador Event. UCSD Medical Center
Aug 2012
Albo M. “What Every Woman Needs to Know about Bladder Control.”
Take the Floor Tonight Symposium, UC San Diego Health System. San
Diego, CA, August 15, 2012
REVIEWER FOR PROFESSIONAL PUBLICATIONS:
1998
1998
2000
2000
2000
2002
–
–
–
–
present
present
present
present
2002
2002
2003
2004
2006
2007
2007
2007
2008
–
–
–
–
–
–
–
–
–
present
present
present
present
present
present
present
present
present
SCI Nursing - Nursing Clinical Practice Guideline. Neurogenic Bladder
Management 15: 1998.
Journal of Endourology
International Urogynecology Journal
Urology
Neurourology and Urodynamics
Urodynamic Testing (published by the National Kidney and Urologic
Diseases Information Clearinghouse)
British Journal of Urology
European Journal of Urology
Journal of Urology
Contemporary Urology
Journal of the American Medical Association
New England Journal of Medicine
Obstetrics & Gynecology
Journal of Sexual Medicine
British Journal of Obstetrics & Gynecology
RESEARCH:
14 | P a g e
1990 – 1991
Research Resident – 100% Dr. William D. Steers, University of Virginia,
Health Sciences Center, Charlottesville, VA.
1995 – 2002
Investigator – 5%, NIH Multi-center Study #U01 DK49960-05: “Medical
therapy in benign prostatic hyperplasia”
1998 – 2000
Investigator – 5%, Glaxo-Welcome Study: “ARIA-3001 transrectal
ultrasounds (TRUS) adverse events and other patient care”
2000 – 2005
Consultant – <5%, NIH # Ro1 AG18339: “Oral DHEA supplementation
replacement in older men and women”
2001 – present
Principal investigator – 15%, NIH # U01 DK60401: “Urinary
Incontinence Treatment Network” (UITN)
Active Protocols
• Urinary Incontinence Treatment Network (UITN) Study - ExtendedTrial of Mid-Urethral Slings (E-TOMUS)
• Urinary Incontinence Treatment Network (UITN) - Value of
Urodynamics Evaluation (ValUE) Treatment Outcomes in Women
with Stress Predominant Urinary Incontinence
• A Multicenter, Long-Term Follow-up Study of the Safety and Efficacy
of Two Dose Levels of BOTOX® (Botulinum Toxin Type A) Purified
Neurotoxin Complex in Patients with Urinary Incontinence Due to
Neurogenic Detrusor Overactivity STUDY NUMBER: 191622-094
Inactive Protocols
• Urinary Incontinence Treatment Network (UITN): Specimen
Repository Protocol
• Urinary Incontinence Treatment Network (UITN): Trial of MidUrethral Slings (TOMUS)
• Urinary Incontinence Treatment Network (UITN): Extended-Stress
Incontinence Surgical Treatment Efficacy Trail (E-SISTEr)
• Urinary Incontinence Treatment Network (UITN): Mixed Incontinence:
Medical or Surgical Approach? (MIMOSA)
• Urinary Incontinence Treatment Network (UITN): Behavior Enhances
Drug Reduction of Incontinence. (BE_DRI)
• Urinary Incontinence Treatment Network (UITN): Stress Incontinence
Surgical Efficacy Trial (SISTEr)
2001 – 2006
Investigator - <5%, NIH # R01 CA90932-01A1: “Analysis of Ras and
Rho Activation in Prostate Cancer”
2002 – 2006
Consultant - <5%, Prostate Profiling Study, ID #U01 CA84998: PI: Dan
Mercola, MD, PhD, Sidney Kimmel Cancer Center, San Diego, CA 92121
2006 – present
Co-Investigator – 5%, R01 - NIH/NICHD 1 U10HD 54214-01 - Pelvic
Floor Disorders Network (PFDN). (NIH/NICHD 2 U10HD 054214-06;
thru 2016)
Active Protocols
• PFDN: Refractory Overactive Bladder Sacral Neuromodulation versus
Botulinum Toxin Assessment (ROSETTA) (UCSD # 120075)
15 | P a g e
•
•
•
•
•
•
•
•
PFDN: Study of Uterine Prolapse Procedures (SUPeR). (UCSD #
130045)
PFDN: Extended Operations and Pelvic Muscle Training in the
Management of Apical Support Loss ( E-OPTIMAL) (100786)
PFDN: Anticholinergic versus Botox Comparision Study (ABC) (UCSD
# 100300)
PFDN: Operations and Pelvic Muscle Training in the Management of
Apical Support Loss OPTIMAL) (UCSD # 080419)
PFDN: ROSETTA Urinary Markers (RUM)
PFDN: Operations and Pelvic Muscle Training in the Management of
Apical Support Loss (OPTIMAL) (UCSD # 080419)
PFDN: Extended Colpopexy and Urinary Reduction Efforts (E-CARE)
(UCSD# 100732)
PFDN: Outcomes Following Vaginal Prolapse Repair and Midurethral
Sling (OPUS) (UCSD # 110136)
2007 –2010
Principal Investigator, Allergan - 191622-515-00 (UCSD Project #
060887) – “A Multicenter, Double-Blind, Randomized, PlaceboControlled, Parallel-Group Study of the Safety and Efficacy of Repeat
Treatment with Two Dose Levels of BOTOX® (Botulinum Toxin Type A)
Purified Neurotoxin Complex Followed by a Treatment with BOTOX® in
Patients with Urinary Incontinence Due to Neurogenic Detrusor
Overactivity”
2007 – 2010
Principal Investigator, Lilly - H6D-MC-LVHK (UCSD Project # 070010) A Randomized, Double-Blind, Placebo-Controlled, Parrallel-Design,
Multicenter Study to Evaluate the Urodynamic Effects of Tadalafil Once a
Day for 12 Weeks in Men with Signs and Symptoms of Benign Prostatic
Hyperplasia
2009 – 2010
Principal Investigator, NIH/NIDDK Sub-Award, New England Research
Institutes (NERI) - 3 U01 DK060401-07S1
2009 – present
Principal Investigator, Allergan - 191622-094 (IUCSD Project #090113)
– “A Multicenter, Long-Term Follow-up Study of the Safety and Efficacy
of Two Dose Levels of BOTOX® (Botulinum Toxin Type A) Purified
Neurotoxin Complex in Patients with Urinary Incontinence Due to
Neurogenic Detrusor Overactivity”
2010 – present
Principal Investigator, NIH/NIDDK Sub-Award, New England Research
Institutes (NERI) – 5 U01 DK058229-03;
RESEARCH ARTICLES:
1. Steers WD, Albo M, van Asselt E: Effects of serotonergic agonists on micturition and
sexual function in the rat. Drug Dev Res 27: 361-75, 1992.
2. Steers WD, Albo M, Tuttle JB: Calcium-channel antagonists prevent urinary-bladder
growth and neuroplasticity following mechanical stress. Am J Physiol (Regulatory
Integrative Comp. Physiol 35) 266(1): R20-R26 Part 2, 1994.
16 | P a g e
3. Tuttle JB, Steers WD, Albo M, Nataluk E: Neural input regulates tissue NGF and growth of
the adult rat urinary bladder. J Auton Nerv Sys 49: 147-58, 1994.
4. Lance R, Albo M, Costabile RA, Steers WD. Oral trazodone as empirical therapy for erectile
dysfunction: a retrospective review. Urology Jul;46(1):117-20, 1995.
5. Albo M, Dupont MC, Raz S: Transvaginal correction of pelvic prolapse. J Endourol 10:
231-39, 1996.
6. Albo M, Dupont MC, Raz S. Anterior flap extraperitoneal cystoplasty. J Urol 157: 209598, 1997.
7. Bernie JE, Hagey S, Albo ME, Parsons CL. The intravesical potassium sensitivity test and
urodynamics: Implications in a large cohort of patients with lower urinary tract symptoms.
J Urol 166: 158-61, 2001.
8. Phelps J, Albo M, Dunn K, Joseph A. Spinal cord injury and sexuality in married or
partnered men: Activities, function, needs, and predictors of sexual adjustment. Arch Sex
Behav 30: 591-602, 2001.
9. Parsons CL, Albo M. Intravesical potassium sensitivity in patients with prostatitis. J Urol
168: 1054-7, 2002.
10. Nager CW, Albo ME. Testing in women with lower urinary tract dysfunction. Clin Obstet
Gynecol 47(1):53-69, 2004.
11. Joseph AC, Albo M. Urodynamics: the incidence of urinary tract infection and autonomic
dysreflexia in a challenging population. Urol Nurs 24(5):390-3, 2004.
12. Rajasekaran M, Wilkes N, Kuntz S, Albo ME. Rho-kinase inhibition suppresses bladder
hyperactivity in spontaneously hypertensive rats. Neurourol Urodyn 2005; 24(3):295-300.
13. Tennstedt S; Urinary Incontinence Treatment Network: Design of the Stress Incontinence
Surgical Treatment Efficacy Trial (SISTEr). Urology. 2005 Dec;66(6):1213-7.
14. Zimmern P, Nager CW, Albo M, Fitzgerald MP, McDermott S; Urinary Incontinence
Treatment Network. Interrater reliability of filling cystometrogram interpretation in a
multicenter study. J Urol. 2006;175(6):2174-7.
15. Urinary Incontinence Treatment Network (UITN). Design of the Behavior Enhances Drug
Reduction of Incontinence (BE-DRI) Study. Contemp Clin Trials. 2007 Jan;2891):48-58.
Epub 2006 Jun 18.
16. Tan JS, Lukacz ES, Menefee SA, Luber KM, Albo ME, Nager CW. Determinants of vaginal
length. Am J Obstet Gynecol 2006 Dec;195(6):1846-50. Epub 2006 Oct 2.
17. Nager CW, Albo ME, FitzGerald MP, McDermott SM, Kraus S, Richter HE, Zimmern P;
Urinary Incontinence Treatment Network. Process for development of multicenter
urodynamic studies. Urology 2007; 69(1): 63-67; discussion 67-8.
18. Nager CW, Albo ME, Fitzgerald MP, McDermott S, Wruck L, Kraus S, Howden N, Norton P,
Sirls L, Varner E, Zimmern P. Reference urodynamic values for stress incontinent women.
Neurourol Urodyn 2007; 26(3): 333-40.
17 | P a g e
19. Albo M, Wruck L, Baker J, Brubaker L, Chai T, Dandreo KJ, Diokno A, Goode P, Kraus S,
Kusek JW, Lemack G, Lowder J, Steers W; Urinary Incontinence Treatment Network. The
relationships among measures of incontinence severity in women undergoing surgery for
stress urinary incontinence. J Urol 2007; 177(5): 1810-4.
20. Albo ME, Richter HE, Brubaker L, Norton P, Kraus S, Zimmern P, Chai TC, Zyczynski H,
Diokno AC, Tennstedt S, Nager C, Lloyd LK, FitzGerald MP, Lemack GE, Johnson HW, Leng
W, Mallett V, Stoddard AM, Menefee S, Varner RE, Kenton K, Moalli P, Sirls L, Dandreo KJ,
Kusek JW, Nyberg LM, and Steers W for the Urinary Incontinence Treatment Network.
Burch colposuspension versus fascial sling to reduce urinary stress incontinence. NEJM
2007 May 24; 356(21):2143-55.
21. Moalli PA, Papas N, Menefee S, Albo M, Meyn L, Abramowitch SD. Tensile properties of five
commonly used mid-urethral slings relative to the TVT. Int Urogynecol J Pelvic Floor
Dysfunct. 2008 May;19(5):655-663. Epub 2008 Jan 9.
22. Richter HE, Diokno A, Kenton K, Norton P, Albo M, Kraus S, Moalli P, Chai TC, Zimmern P,
Litman H, Tennstedt S; Urinary Incontinence Treatment Network. Predictors of Treatment
Failure 24 Months after Surgery for Stress Urinary Incontinence. J Urol 2008
Mar;179(3):1024-1030. Epub 2008 Jan 18.
23. Urinary Incontinence Treatment Network. The Trial of Mid-Urethral Slings (TOMUS): Design
and Methodology. J Applied Res. 2008;8(1):1-13.
24. Burgio KL, Kraus SR, Menefee S, Borello-France D, Corton M, Johnson HW, Mallett V,
Norton P, FitzGerald MP, Dandreo KJ, Richter HE, Rozanski T, Albo M, Zyczynski HM,
Lemack GE, Chai TC, Khandwala S, Baker J, Brubaker L, Stoddard AM, Goode PS, NielsenOmeis B, Nager CW, Kenton K, Tennstedt SL, Kusek JW, Chang TD, Nyberg LM, Steers W;
Urinary Incontinence Treatment Network. Behavioral therapy to enable women with urge
incontinence to discontinue drug treatment: a randomized trial. Ann Intern Med 2008 Aug
5;149(3):161-9.
25. Chai TC, Albo ME, Richter HE, Norton PA, Dandreo KJ, Kenton K, Lowder JL, Stoddard
AM; Urinary Incontinence Treatment Network. Complications in women undergoing Burch
colposuspension versus autologous rectus fascial sling for stress urinary incontinence. J
Urol. May 2009; 181(5):2192-2197.
26. Anger JT, Weinberg AE, Albo ME, Smith AL, Kim JH, Rodríguez LV, Saigal CS. Trends in
surgical management of stress urinary incontinence among female Medicare beneficiaries.
Urology. Aug 2009;74(2):283-287.
27. Brubaker L, Moalli P, Richter HE, Albo M, Sirls L, Chai T, Kraus SR, Norton P, Chang D,
Tennstedt SL. Challenges in designing a pragmatic clinical trial: the mixed incontinence medical or surgical approach (MIMOSA) trial experience. Clin Trials. Aug 2009;9(4):355364.
28. Nager CW, Brubaker L, Daneshgari F, Litman HJ, Dandreo KJ, Sirls L, Lemack GE, Richter
HE, Leng W, Norton P, Kraus SR, Chai TC, Chang D, Amundsen CL, Stoddard AM,
Tennstedt SL; Urinary Incontinence Treatment Network. Design of the Value of Urodynamic
Evaluation (ValUE) Trial: A non-inferiority randomized trial of preoperative urodynamic
investigations. Contemp Clin Trials. 2009 Nov;30(6):531-9. Epub 2009 Jul 25.
18 | P a g e
29. Kraus SR, Smochowski R, Albo ME, Xu L, Klise SR, Roehrborn CG. Urodynamic
standardization in a large-scale, multicenter clinical trial examining the effects of daily
tadalafil in men with lower urinary tract symptoms with or without benign prostatic
obstruction. Neurourol Urodyn. Jun 2010;29(5):741-747.
30. Richter HE, Albo ME, Zyczynski HM, Kenton K, Norton PA, Sirls LT, Kraus SR, Chai TC,
Lemack GE, Dandreo KJ, Varner RE, Menefee S, Ghetti C, Brubaker L, Nygaard I,
Kandwala S, Rozanski TA, Johnson H, Schaffer J, Stoddard AM, Holley RL, Nager CW,
Moalli P, Mueller E, Arisco AM, Corton M, Tennstedt S, Chang TD, Gormley EA, Litman HJ;
the Urinary Incontinence Treatment Network. Retropubic versus transobturator
midurethral slings for stress incontinence. N Engl J Med. 2010 Jun 3;362(22):2066-76.
Epub 2010 May 17.
31. Sirls LT, Tennstedt S, Albo M, Chai T, Kenton K, Huang L, Stoddard AM, Arisco A, Gormley
EA. Factors associated with quality of life in women undergoing surgery for stress urinary
incontinence. J Urol. 2010 Dec;184(6):2411-5. Epub 2010 Oct 16.
32. Woldrch JM, Palazzi-Churas K, Lakin C, Albo M, Parsons JK. Prostate laser vaporization in
men with urinary retention. BJU Int. Aug 2011;108(3):395-398. Epub 2011 Apr 11.
33. Brubaker L, Norton PA, Albo ME, Chai TC, Dandreo KJ, Lloyd KL, Lowder JL, Sirls LT,
Lemack GE, Arisco AM, Xu Y, Kusek JW; Urinary Incontinence Treatment Network. Adverse
events over two years after retropubic or transobturator midurethral sling surgery: Findings
from the Trial of Midurethral Slings (TOMUS) Study. Am J Obstet Gynecol. 2011
Nov;205(5):498.e1-6. Epub 2011 Jul 20.
34. Kraus SR, Lemack GE, Sirls LT, Chai TC, Brubaker L, Albo M, Leng WW, Lloyd LK, Norton
P, Litman HJ; Urinary Incontinence Treatment Network. Urodynamic Changes Associated
with Successful Stress Urinary Incontinence Surgery: Is a Little Tension a good
Thing? Urology. 2011 Dec;78(6):1257-62. Epub 2011 Oct 11.
35. Kraus SR, Lemack GE, Richter HE, Brubaker L, Chai TC, Albo ME, Sirls LT, Leng WW,
Kusek JW, Norton P, Litman HJ; Urinary Incontinence Treatment Network. Changes in
Urodynamic Measures Two Years after Burch Colposuspension or Autologous Sling
Surgery. Urology. 2011 Dec;78(6):1263-8. Epub 2011 Oct 11.
36. Brubaker L, Richter HE, Norton PA, Albo M, Zyczynski HM, Chai TC, Zimmern P, Kraus S,
Sirls L, Kusek JW, Stoddard A, Tennstedt S, Gormley EA; Urinary Incontinence Treatment
Network. 5-year continence rates, satisfaction and adverse events of burch urethropexy
and fascial sling surgery for urinary incontinence. J Urol. 2012 Apr;187(4):1324-30. Epub
2012 Feb 15.
37. Nager CW, Brubaker L, Litman HJ, Zyczynski HM, Varner RE, Amundsen C, Sirls LT,
Norton PA, Arisco AM, Chai TC, Zimmern P, Barber MD, Dandreo KJ, Menefee SA, Kenton
K, Lowder J, Richter HE, Khandwala S, Nygaard I, Kraus SR, Johnson HW, Lemack GE,
Mihova M, Albo ME, Mueller E, Sutkin G, Wilson TS, Hsu Y, Rozanski TA, Rickey LM, Rahn
D, Tennstedt S, Kusek JW, Gormley EA; the Urinary incontinence Treatment Network. A
Randomized Trial of Urodynamics Testing before Stress-Incontinence Surgery. N Engl J
Med. 2012 May 24; 336(21):1987-97. Epub 2012 May
38. Richter HE, Brubaker L, Stoddard AM, Xu Y, Zyczynski HM, Norton P, Sirls LT, Kraus SR,
Chai TC, Zimmern P, Gormley EA, Kusek JW, Albo ME; Urinary Incontinence Treatment
Network. Patient Related Factors Associated with Long-Term Urinary Continence After
19 | P a g e
Burch Colposuspension and Pubovaginal Fascial Sling Surgeries. J. Urol. 2012
Aug;188(2):485-9. Epub 2012 Jun 15.
39. Brown JM, Barbe MF, Albo ME, Lai HH, Ruggieri MR Sr. Anatomical feasibility of
performing intercostal and ilioinguinal nerve to pelvic nerve transfer: a possible technique
to restore lower urinary tract innervation. J Neurosurg Spine. 2012 Oct;17(4):357-62.
Epub 2012 Aug 10.
40. Albo ME, Litman HJ, Richter HE, Lemack GE, Sirls LT, Chai TC, Norton P, Kraus SR,
Zyczynski H, Kenton K, Gormley EA, Kusek JW; Urinary Incontinence Treatment Network.
Treatment success of retropubic and transobturator mid urethral slings at 24 months. J
Urol. 2012 Dec;188(6):2281-7. Epub 2012 Oct 22.
41. Brown JM, Barbe MF, Albo ME, Ruggieri MR Sr. Anatomical feasibility of performing a
nerve transfer from the femoral branch to bilateral pelvic nerves in a cadaver: a potential
method to restore bladder function following proximal spinal cord injury. J Neurosurg
Spine. 2013 Jun;18(6):598-605. Epub 2013 Mar 29.
INVITED ARTICLES & REVIEWS:
1. Raz S, Albo ME. A new approach in the treatment of urethral incontinence: The
anterior vaginal wall sling. Issues in Incontinence 3(1), Winter 1996. (Newsletter)
2. Gray M, Albo M, Huffstutler S. Interstitial cystitis: A guide to recognition, evaluation,
and management for nurse practitioners. J WOCN 29: 93-102, 2002.
3. Albo M, Brubaker L, Daneshgari F. Open and unresolved clinical questions in female
pelvic medicine and reconstructive surgery. BJU Int 2006; 98(S1): 110-116.
BOOK CHAPTERS:
1.
Dupont MC, Albo ME, Raz S. Diagnosis of stress urinary incontinence: An overview.
Urol Clin North Am 23: 407-15, 1996.
2.
Albo M, Dupont M, Raz S. Transvaginal bladder neck suspension. In Operative
Urology, Krane et al. (eds), Churchill Livingstone, Philadelphia, Chapter 34, pp 223-9,
2000.
3.
Albo M. Selecting the best surgical option for the treatment of stress urinary
incontinence, [invited] chapter in Female Urology, edited by Raz S and Rodriguez L;
Elsevier. Chapter 29. Release Date: May 22, 2008.
4.
Albo M. “Bladder Emptying: “Clinical Obstruction” in Urodynamics – Rapid and
Practical Interpretation, Eric Rovner and Dr. Michelle Koski, Editors. (In-progress)
ABSTRACTS:
20 | P a g e
** denotes abstract presented by Dr. Albo
1991
**Albo M, Tuttle JB, Creedon DJ, Steers WD. Calcium antagonists prevent smooth muscle
hypertrophy and neural plasticity associated with bladder outlet obstruction. Soc for
Neuroscience Abstr 17: 1498, 1991.
Steers WD, Tuttle JB, von Asselt E, Albo M. Differential effects of serotonergic (5-HT) agonists
on neural control of micturition and sexual function. Soc for Neuroscience Abstr 17: 721,
1991.
**Albo M, Nataluk E, Steers WD, Tuttle JB. Morphological functional and neurotrophic
alterations in partially decentralized and denervated bladders. J Urol 145: 308A, 1991.
1992
Steers WD, Albo M, Roberts BJ, Tuttle JB. Prevention of morphological and functional
sequelae of bladder outlet obstruction by calcium antagonists and alpha adrenergic blockers.
J Urol 147: 350A, 1992.
1993
**Albo M, Steers WD. Oral trazodone as initial therapy for management of impotence. J Urol
149: 244A, 1993.
1996
Dupont MC, Albo ME, Raz S. A videourodynamic evaluation of bladder neck competence in
females. J Urol 155: 536A, 1996.
1997
Ginsberg DA, Rovner ES, Albo ME, Raz S. 2-year experience with a new technique for
transvaginal repair of grade IV cystocele. J Urol 157: 462, 1997.
Rovner ES, Ginsberg DA, Albo ME, Raz S. Anterior flap extraperitoneal cystoplasty (AFEC): A
simplified method of ileal augmentation cystoplasty. J Urol 157: 397, 1997.
2000
Gabal-Shehab LL, Nager CW, Albo M. Bilateral singe-system ureteral ectopy to the proximal
urethra presenting as new onset urinary incontinence in a 72-year-old woman. Western
Section AUA, November 5-9, 2000. Palm Desert, CA.
Kamarei M, Bernie JE, Joseph A, U HS, Albo M. The Brindley neurostimulator for volitional
bladder and bowel control in patients with spinal cord injury - the San Diego experience.
Western Section AUA, November 5-9, 2000. Palm Desert, CA.
2003
Wilkes N, Zupkas PF, Albo M. Urethral absorption of lidocaine. J Urol 169 (4 Suppl): 71,
Abstract #274, 2003.
Wilkes N, Albo M, Rajasekaran M. Rho-kinase inhibition suppresses bladder overactivity in
spontaneously hypertensive rats. J Urol 169 (4 Suppl): 316, Abstract #1229, 2003.
White S, Albo M, Wilkes N, Rajasekaran M. 8-iso-PGF2A, an oxidative stress marker, impairs
erectile function in a rat model. J Urol 169 (4 Suppl): 360, Abstract #1345, 2003.
21 | P a g e
White S, Albo M, Wilkes N, Rajasekaran M. Y-27632, an inhibitor of rho-kinase, attenuates
prostanoid-induced erectile dysfunction in a rat model. J Urol 169 (4 Suppl): 363, Abstract
#1357, 2003.
2004
Zimmern P, Nager C, Albo M, Fitzgerald M, Mohr B, McDermott S. Urodynamic inter-rater
reliability between local and central physician reviewers for the filling cystometrogram in
SISTEr (Stress Incontinence Surgical Treatment Efficacy Trial). Neurourol Urodyn 23: 419420, Abstract #16, 2004.
Zimmern P, Nager C, Albo M, Fitzgerald M, Mohr B, McDermott S. Interpretation of pressureflow studies: Inter-rater reliability between central reviewers in SISTEr (Stress Incontinence
Surgical Treatment efficacy Trial), a multi-center stress incontinence surgery trials.
Neurourology and urodynamics, volume 23: 5/6, 2004.
Rajasekaran M, Kuntz S, Wilkes N, Albo M. Role of oxidative stress in age-related bladder
dysfunction: the Brown-Norway rate model. AUA Annual Meeting, San Francisco, CA. May 813, 2004.
Kuntz S, White S, Albo M, Rajasekaran M. Erectile dysfunction and oxidative stress-mediated
cavernosal cell death in spontaneously hypertensive rats. AUA Annual Meeting, San Francisco,
CA. May 8-13, 2004.
Rajasekaran M, Kuntz S, Wilkes N, Albo M. Y-27632, a specific inhibitor of rho-kinase,
improves bladder function in a rat model of hyperactivity. AUA Annual Meeting, San
Francisco, CA. May 8-13, 2004.
White S, Albo M, Rajasekaran M. Bosentan, an endothelin receptor antagonist, potentiates
nitric oxide-mediated erectile response in an aging Brown-Norway rat model. AUA Annual
Meeting, San Francisco, CA. May 8-13, 2004.
2005
Song YS, Saljooque F, Sang UH, Crissien AM, Albo ME, Rajasekaran M. Transdifferentiation of
rat fetal brain stem cells into bladder smooth muscle cells. J Urol 173 (4 Suppl): 36, Abstract
#134, 2005.
Downs TM, Arsanjani A, Sakamoto K, Weedin J, Wang-Rodriguez J, Schmidt J, and Albo M.
Contemporary clinical characteristics and outcomes of prostate cancer patients treated within
the Veterans Affairs Health Care System: Data from SURF (San Diego Urologic Research
Foundation) Prostate Cancer Database. Abstract No. 09-23. Western American Urologic
Association Annual Meeting, Vancouver, Canada, July 2005.
Arsanjani A, Wang-Rodriguez J, Roesch SC, Kostelec M, Modder JK, Schmidt JD, Albo M and
Downs TM. Are clinical risk group stratification and pathologic Gleason score equally predictive
of biochemical disease recurrence: Data from the SURF (San Diego Urologic Research
Foundation) Prostate Cancer Database. Abstract No. 09-24. Western American Urologic
Association Annual Meeting, Vancouver, Canada, July 2005.
Nager C, Albo M, Fitzgerald MP, Wruck L, McDermott S, Norton P, Krauss S, Howden N, Sirls
L, Varner E, Zimmern P, for the Urinary Incontinence Treatment Network. Non-invasive
uroflowmetry and filling cystometry values in a large cohort of women undergoing surgery for
pure or predominant stress urinary incontinence. Presented at International Continence
Society Congress 2005 as a Poster Abstract. Montreal, Canada, September 1, 2005.
2006
22 | P a g e
Baquir A, Kim HW, Albo M, Rajasekaran M. Characterization of chronic partial bladder outlet
obstruction-related alterations to erectile function in male rats. J Urol 175 (4 Suppl):389,
Abstract #1209, 2006.
Kim HW, Baquir A, Albo M, Rajasekaran M. H-1152, a novel inhibitor of Rho-kinase, improves
bladder function in a rat model of partial bladder outlet obstruction. J Urol 175 (4 Suppl):418,
Abstract #1297, 2006.
Baquir A, Kim HW, Albo M, Rajasekaran. Chronic partial bladder outlet obstruction does not
alter erectile dysfunction. AUA Annual Meeting, San Antonio, TX, May 21–26, 2006.
**Albo M, Rovner ER, Mullins CD, Becker R, Jumadilova Z, Benner J. Overactive bladder
symptom bother is more prevalent in men than women at older ages. Western Section
American Urological Association Annual Meeting, Maui, HI, October 22, 2006.
2007
**Albo ME, Richter HE, Brubaker L, Norton PA, Kraus S, Zimmern P, et al. Podium
presentation: “Results of the SISTEr randomized surgical trial comparing the autologous rectus
fascia sling to the Burch colposuspension.” American Urological Association Annual Meeting,
Anaheim, CA, May 22, 2007.
Norton P, Rickter H, Chai T, Albo M, FitzGerald MP, Stoddard A, Zimmern P. Moderated poster:
“Voiding symptoms are common on women planning continence surgery.” American Urological
Association Annual Meeting, Anaheim, CA, May 21, 2007.
2009
Weinberg AE, Anger JT, Kim J-H, Albo ME, Rodriguez LV, Saigal CS. Trends in the surgical
management of stress urinary incontinence among female Medicare beneficiaries [abstract
198]. J Urol. 2009;181(4 Suppl):73.
2010
Sirls L, Tennstedt S, Albo M, Chai T, Kenton K, Gormley EA, Arisco A. Quality of life in women
with stress urinary incontinence seeking surgery [abstract 1776]. J Urol. 2010;183(4
Suppl):e688.
**Albo M. The Results of the Randomized Trial of Retropubic and Transobturator midurethral
Slings (TOMUS). AUA Annual Meeting, San Francisco, CA. May 2010.
2011
Albo M. Urodynamics/Incontinence/Female Urology: Incontinence: Evaluation & Therapy –
Podium. “Baseline and time-Varying Factors Associated with Long-Term continence Outcomes
Up to 7 Years after Surgery for Stress Urinary Incontinence. “ AUA Annual Meeting,
Washington, DC. May 14-19, 2011.
Albo M. Urodynamics/Incontinence/Female Urology: Incontinence: Evaluation & Therapy Moderated Poster. “Twenty-Four Month Outcomes of Randomized Equivalence Trial of
Retropubic and Transobturator midurethral Slings (TOMUS).” AUA Annual Meeting,
Washington, DC. May 14-19, 2011.
Albo M. Urodynamics/Incontinence/Female Urology: Urodynamics Testing - Moderated
Poster. “Urodynamics Changes 12 Months after Retropubic and Transobturator Midurethral
Slings.” AUA Annual Meeting, Washington, DC. May 14-19, 2011.
23 | P a g e
L Brubaker, P Norton, T. Chai, M. Albo, K. J. Dandreo, G. Lemack, J. Lowder, K. Lloyd, L Sirls,
A. Arisco and J. W. Kusek for the Urinary Incontinence Treatment Network. Adverse Events in
the TOMUS Trial.
Stephen Kraus*, San Antonio, TX, Gary Lemack, Dallas, TX, Toby Chai, Baltimore, MD, Wendy
Leng, Pittsburgh, PA, Michael Albo, La Jolla, CA, Elizabeth Mueller, Maywood, IL, Larry Sirls,
Royal Oak, MI, Tracey Wilson, Birmingham, AL, Liyuan Huang, Heather Litman, Watertown,
MA, for the Urinary Incontinence Treatment Network. Urodynamic Changes 12 months after
Retropubic and Transobturator Midurethral Slings.
24 | P a g e

M E A

Transcription

Similar documents